SEC 13F Intelligence

Charles Schwab Investment Management Inc / LLY

Charles Schwab Investment Management Inc’s Eli Lilly & Co Position

Does Charles Schwab Investment Management Inc own Eli Lilly & Co (LLY)? Yes — 5.90M shares worth $5.4B (+0.83% of its 13F portfolio) as of Q1 2026, up from 5.76M shares the prior filed quarter.

Position Value
$5.4B
Q1 2026
Shares
5.90M
% of Portfolio
+0.83%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $470MQ4 ’18Q1 ’19: $529MQ2 ’19: $441MQ3 ’19: $438MQ4 ’19: $508MQ4 ’19Q1 ’20: $527MQ2 ’20: $639MQ3 ’20: $530MQ4 ’20: $606MQ4 ’20Q1 ’21: $670MQ2 ’21: $841MQ3 ’21: $859MQ4 ’21: $1.0BQ4 ’21Q1 ’22: $1.1BQ2 ’22: $1.2BQ3 ’22: $1.4BQ4 ’22: $1.6BQ4 ’22Q1 ’23: $1.5BQ2 ’23: $2.0BQ3 ’23: $2.4BQ4 ’23: $2.7BQ4 ’23Q1 ’24: $3.6BQ2 ’24: $4.4BQ3 ’24: $4.3BQ4 ’24: $3.9BQ4 ’24Q1 ’25: $4.3BQ2 ’25: $4.2BQ3 ’25: $4.3BQ4 ’25: $6.2BQ4 ’25Q1 ’26: $5.4Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.90M$5.4B+0.83%
Q4 20255.76M$6.2B+0.96%
Q3 20255.63M$4.3B+0.69%
Q2 20255.36M$4.2B+0.72%
Q1 20255.26M$4.3B+0.81%
Q4 20245.04M$3.9B+0.72%
Q3 20244.84M$4.3B+0.82%
Q2 20244.83M$4.4B+0.83%
Q1 20244.67M$3.6B+0.84%
Q4 20234.56M$2.7B+0.67%
Q3 20234.44M$2.4B+0.68%
Q2 20234.35M$2.0B+0.58%
Q1 20234.31M$1.5B+0.45%
Q4 20224.28M$1.6B+0.50%
Q3 20224.21M$1.4B+0.49%
Q2 20223.84M$1.2B+0.43%
Q1 20223.87M$1.1B+0.33%
Q4 20213.79M$1.0B+0.31%
Q3 20213.72M$859M+0.28%
Q2 20213.67M$841M+0.28%
Q1 20213.59M$670M+0.25%
Q4 20203.59M$606M+0.24%
Q3 20203.58M$530M+0.24%
Q2 20203.89M$639M+0.31%
Q1 20203.80M$527M+0.31%
Q4 20193.87M$508M+0.27%
Q3 20193.91M$438M+0.26%
Q2 20193.98M$441M+0.27%
Q1 20194.08M$529M+0.34%
Q4 20184.06M$470M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Charles Schwab Investment Management Inc’s full portfolio or all institutional holders of LLY.